Concentric Capital Strategies »

Syndax Pharmaceuticals shares owned by Concentric Capital Strategies

Quarter-by-quarter ownership of Syndax Pharmaceuticals (SNDX) shares owned by Concentric Capital Strategies from 13F filings

Historical chart of Concentric Capital Strategies investment in Syndax Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Syndax Pharmaceuticals held by Concentric Capital Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Syndax Pharmaceuticals by Concentric Capital Strategies

Quarter filed Position value Share count Share price at filing
2025-09-30 $338k 22k 15.39

More positions owned by Concentric Capital Strategies

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Kellogg Company Put Option (K)
Potlatch Corporation Call Option (PCH)
Microsoft Corporation (MSFT)
Packaging Corporation of America (PKG)
Apple (AAPL)
Rayonier Call Option (RYN)
Madison Square Grdn Sprt Cor Cl A (MSGS)
Steel Dynamics (STLD)
Amazon (AMZN)
L3harris Technologies (LHX)
WESCO International (WCC)
Coinbase Global Com Cl A (COIN)
NVIDIA Corporation (NVDA)
Meta Platforms Cl A (META)

View all positions for Concentric Capital Strategies

Top funds holding Syndax Pharmaceuticals

BlackRock
Kynam Capital Management
Goldman Sachs Group
Vanguard Group
Point72 Asset Management
State Street Corporation
Eversept Partners
Adage Capital Partners GP
Kingdon Capital Management
Franklin Resources
Geode Capital Management
Soleus Capital Management
Assenagon Asset Management
UBS Group
Qube Research & Technologies

View all funds holding Syndax Pharmaceuticals